Navigating Challenges in Treatment of Attention Deficit Hyperactivity Disorder (ADHD)
In this episode of MEDcast, the expert panelists review newest guidance for prescription of controlled substances using telemedicine, ADHD medication shortage, and approved and emerging stimulants and non-stimulants for the treatment of ADHD.
Other Articles in this Edition
Narcolepsy Drug Might Be New Treatment Option for ADHD
The A.D.H.D. Drug Shortage Is Causing Real Pain (Opinion)
ADHD Appears Underdiagnosed in Patients at a Pediatric Headache Clinic
DEA extends pandemic telehealth rules for prescribing controlled substances
ADHD drug maker suing DEA over ‘effectively shutting down’ manufacturing
3 Reasons Why More Students Are in Special Education
New research finds greater continuity of psychotherapy after shift to telehealth
Report: Impacts of climate change threaten children’s mental health starting before birth
Navigating Challenges in Treatment of Attention Deficit Hyperactivity Disorder (ADHD)